TGF-ß1 potentiates V?9Vd2 T cell adoptive immunotherapy of cancer. (2021)
Attributed to:
King's Health Partners Confidence in Concept
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.xcrm.2021.100473
PubMed Identifier: 35028614
Publication URI: http://europepmc.org/abstract/MED/35028614
Type: Journal Article/Review
Volume: 2
Parent Publication: Cell reports. Medicine
Issue: 12
ISSN: 2666-3791